Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Zerbaxa is a newly approved combination antibiotic used concomitantly with metronidazole to treat adults with complicated intraabdominal infections and as monotherapy to treat complicated urinary tract infections. Zerbaxa is a combination of ceftolozane and tazobactam.

 

* Patients with diminished renal function will require lower doses, and the drug may be less effective in such patients.